Is Lipoprotein(a) a Risk Factor for Blood Clots? Gregory Piazza and Team Publish Landmark Study
Gregory Piazza, Director of the Vascular Medicine Section at Brigham and Women’s Hospital, posted on LinkedIn:
”Lipoprotein(a) is a known risk factor for atherosclerotic cardiovascular disease, including heart attack. Testing for lipoprotein(a) is even a recommendation in some guidelines to identify patients at risk for early heart disease. But is lipoprotein(a) a risk factor for venous thrombosis as well? A recent publication from my group explores the links between lipoprotein(a) and blood clots.”
Read the full article here.
Title: Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications
Authors: Mariana B Pfeferman, Sina Rashedi, Gregory Y H Lip, Christian Weber, Michelle L O’Donoghue, Steven Nissen, Stephen J Nicholls, Pradeep Natarajan, Jorge Plutzky, Peter Libby, Samuel Z Goldhaber, Gregory Piazza, Behnood Bikdeli
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs